"还氧化状态对人类质母细胞瘤T98G细胞系中超素介导的即时光动力疗法的影响"
Camila Aparecida Errerias Fernandes Cardinali1, Camila Fabiano de Freitas2, Renato Sonchini Gonçalves3
1Departament of Physiological Sciences, State University of Maringa, Maringa, Parana 87020-900, Brazil.
ACS omega
|January 20, 2025
概括
这项研究研究了光动力学疗法 (PDT),使用超素 (Hyp) 脂质体与布氨酸硫胺 (BSO) 结合治疗质母细胞瘤. 降低的谷氨 (GSH) 水平并没有提高PDT的有效性,这表明GSH不是Hyp诱导的细胞死亡的关键.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 纳米医学是一种纳米医学.
背景情况:
- 多形质母细胞瘤 (GBM) 对化疗具有很高的耐药性,部分原因是由于谷氨 (GSH) 调节细胞的氧化还原状态.
- 光动力学疗法 (PDT) 通过产生活性氧物种 (ROS) 提供了选择性,最小侵入性的癌症治疗方法.
研究的目的:
- 评估PDT使用DPPC/F127-B脂质体中配制的海皮素 (Hyp) 与布氨酸硫胺 (BSO) 结合对抗T98G人类质母细胞瘤细胞系的疗效.
- 为了确定抑制GSH合成是否增强了低介导PDT效应.
主要方法:
- 人类质母细胞T98G细胞被用低负荷DPPC/F127-B脂质体治疗,有或没有BSO,一种GSH合成抑制剂.
- 细胞吸收Hyp,细胞内ROS生成,GSH水平和细胞死亡被量化.
- 评估了脂质体配方和Hyp递送效率.
主要成果:
- DPPC/F127-B脂质体有效地将Hyp传递给T98G细胞,显示ROS的剂量依赖性增加.
- 在特定的Hyp度下,BSO降低了GSH水平并增强了ROS生成,但没有改善细胞死亡.
- 仅用Hyp脂酶治疗的细胞中细胞死亡更为显著,这表明减少GSH对PDT疗效并不关键.
结论:
- 混合DPPC/F127-B脂质体作为高素在质母细胞瘤治疗中的有效输送系统.
- 结合BSO和高素PDT并没有优化对T98G细胞的治疗结果,因为降低的GSH水平对PDT效应没有决定性作用.
更多相关视频
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...